Nandrolone
is
chemically
related
to the male hormone. Compared to testosterone, it has an enhanced anabolic and
a
reduced androgenic
activity. This has been demonstrated in
animal bioassays and
explained
by receptor binding
studies. The low androgenicity of nandrolone is confirmed in clinical use.
In the human, nandrolone has been shown to positively
influence
calcium metabolism and
to
increase
bone mass
in osteoporosis.
In women with disseminated mammary carcinoma, Nandrolone has been
reported to
produce objective regressions for
many months. Furthermore,
Nandrolone has a nitrogen-saving
action. This
effect
on protein metabolism has been
established
by
metabolic studies and is utilised therapeutically in
conditions where a protein deficiency
exists such as
during chronic debilitating diseases
and
after major surgery and severe trauma. In these conditions, Nandrolone Phenylpropionate serves as
a supportive adjunct to specific therapies
and
dietary
measures as well as parenteral
nutrition,
due
to
it's faster acting nature Nandrolone phenylpropionate is preffered in situations where a faster clinical
response is required over
it's chemical variant Nandrolone decaonate.